Fox Chase Cancer Center News

PHILADELPHIA (April 5, 2016) —  "Our findings have broad implications for the design of future clinical trials and the interpretation of current and previous studies,” said lead study investigator Nicholas G. Zaorsky, MD, resident physician in radiation oncology at Fox Chase.

PHILADELPHIA (April 5, 2016) — The award, recognizing leadership in nursing practice, administration, research and nursing education. will be announced at the 2016 induction ceremony for the Delta Tau Chapter-at-Large on Sunday, April 10, at Holy Family University.

PHILADELPHIA (April 4, 2016) – Temple Head & Neck Institute and Fox Chase Cancer Center Collaborate to Offer Free Screenings During Oral, Head and Neck Cancer Awareness Week^®.

PHILADELPHIA (March 28, 2016) — Steven J. Cohen, MD, chief of gastrointestinal medical oncology at Fox Chase Cancer Center, has been elected by his peers to serve as Vice Chair of the NCI Pancreas Task Force of the Gastrointestinal Steering Committee (GISC).

PHILADELPHIA (March 24, 2016) — Richard E. Greenberg, MD, FACS, chief of urologic oncology at Fox Chase Cancer Center, will receive the 2016 American Urologic Association (AUA)’s Residents Committee Teaching Award at the organization’s annual meeting in San Diego this May.

​PHILADELPHIA (March 22, 2016) — Mohan Doss, PhD, MCCPM, will receive the Outstanding Leadership Award in the field of dose-response on behalf of Scientists for Accurate Radiation Information at the 15th Annual International Conference of the International Dose-Response Society in Amherst, MA.

PHILADELPHIA (March 21, 2016) — Faculty, staff, volunteers, patients, survivors, and their families will come together as members of the Fox Chase Cancer Center team for the Colon Cancer Coalition’s Annual Get Your Rear in Gear run/walk on Sunday, April 3, 2016. The family-friendly 4-mile run, 2-mile walk, and kids fun run will take place at the Please Touch Museum in Memorial Hall.

PHILADELPHIA (March 9, 2016) – Fox Chase Cancer Center researchers recently showed that renal mass biopsy enabled accurate diagnosis of renal cell carcinoma. It can also be used to stratify patients based on disease risk — potentially minimizing the risk of over- or under-treatment in groups who could be on surveillance versus those who need surgery because of more aggressive renal tumors.